The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Expanding the indication spectrum

Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation

EuroIntervention 2013;9:R127-R135. DOI: 10.4244/EIJV9SRA22

1. Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; 2. Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland; 3. Heart Centre,

The prevalence of chronic kidney disease (CKD) and end-stage renal disease continues to increase worldwide. Hypertension and diabetes are recognised as two major factors contributing to further progression of CKD. Importantly

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Efficacy of baroreflex activation therapy for the treatment of resistant hypertension